BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8886740)

  • 1. Cervical spontaneous epidural hematoma as a complication of non-Hodgkin's lymphoma.
    Mastronardi L; Carletti S; Frondizi D; Spera C; Maira G
    Eur Spine J; 1996; 5(4):268-71. PubMed ID: 8886740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphoma.
    Arranz R; Pérez G; Steegmann JL; Cámara R; Tomás JF; Figuera A; Vazquez L; Fernández-Rañada JM
    Am J Hematol; 1991 Sep; 38(1):75-6. PubMed ID: 1716853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results with MACOP-B in the treatment of aggressive non-Hodgkin's lymphomas. The experience in Brazil.
    Costa MA; Rabinowits M; Froimtchuk MJ; Olivatto LO; Allan SE; Gil RA; Andrade CA; Martino JL; Dobbin JA; Carriço MK
    Am J Clin Oncol; 1994 Aug; 17(4):323-7. PubMed ID: 7519390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing toxicity of MACOP-B.
    Connors JM; Klimo P
    J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
    Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
    Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors.
    Ibrahim EM; Bunyan RF; al-Mulhim FA; al-Nabhan AA; Ibrahim RE
    Acta Haematol; 1996; 96(3):126-34. PubMed ID: 8876608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
    Hryniuk W
    N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
    Burney IA; Malik IA
    J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
    Eifel PJ; McClure S
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
    [No Abstract]   [Full Text] [Related]  

  • 12. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
    Mazza P; Zinzani PL; Martelli M; Fiacchini M; Bocchia M; Pileri S; Falini B; Martelli MF; Amadori S; Papa G
    Leuk Lymphoma; 1995 Feb; 16(5-6):457-63. PubMed ID: 7540460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
    De Sanctis V; Alfò M; Di Rocco A; Ansuinelli M; Russo E; Osti MF; Valeriani M; Minniti G; Grapulin L; Musio D; Bracci S; Spagnoli A; Moleti ML; Tombolini V; Martelli M
    Hematol Oncol; 2017 Dec; 35(4):554-560. PubMed ID: 28078727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
    Nielsen H
    Eur J Haematol; 1991 Feb; 46(2):123-4. PubMed ID: 1995324
    [No Abstract]   [Full Text] [Related]  

  • 16. Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.
    Yamada T; Shinohara K; Takeda K; Kameda N; Katsuki K; Ariyoshi K; Kamei T
    Jpn J Clin Oncol; 1999 Apr; 29(4):226-8. PubMed ID: 10340048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
    Kohda K; Tsuji A; Takayanagi N; Takeda M; Hayashi S; Takimoto R; Fujisaki Y; Tsuji Y; Ezoe A; Nakazawa O
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2183-9. PubMed ID: 7694548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.
    Klimo P; Connors JM
    Ann Intern Med; 1985 May; 102(5):596-602. PubMed ID: 2580468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.